Structure and activity of the DHNA Coenzyme-A Thioesterase from Staphylococcus aureus providing insights for innovative drug development

Humanity is facing an increasing health threat caused by a variety of multidrug resistant bacteria. Within this scenario, Staphylococcus aureus , in particular methicillin resistant S. aureus (MRSA), is responsible for a number of hospital-acquired bacterial infections. The emergence of microbial antibiotic resistance urgently requires the identification of new and innovative strategies to treat antibiotic resistant microorganisms. In this context, structure and function analysis of potential drug targets in metabolic pathways vital for bacteria endurance, such as the vitamin K 2 synthesis pathway, becomes interesting. We have solved and refined the crystal structure of the S. aureus DHNA thioesterase ( Sa DHNA), a key enzyme in the vitamin K 2 pathway. The crystallographic structure in combination with small angle X-ray solution scattering data revealed a functional tetramer of Sa DHNA. Complementary activity assays of Sa DHNA indicated a preference for hydrolysing long acyl chains. Site-directed mutagenesis of Sa DHNA confirmed the functional importance of Asp16 and Glu31 for thioesterase activity and substrate binding at the putative active site, respectively. Docking studies were performed and rational designed peptides were synthesized and tested for Sa DHNA inhibition activity. The high-resolution structure of Sa DHNA and complementary information about substrate binding will support future drug discovery and design investigations to inhibit the vitamin K 2 synthesis pathway.